BEDFORD, Mass., Oct. 20 Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the Company will host a meeting for members of the investment community at the RSNA (Radiological Society of North America) trade show in Chicago, IL. RSNA is the world's largest medical meeting with over 60,000 radiologists, technologists, administrators and vendors expected to attend. For more information about RSNA, please visit http://rsna2009.rsna.org/newsroom.
Advertisement
Hologic's investor meeting will be held on Tuesday, December 1, 2009, at McCormick Place from 8:00 to 10:00 a.m. (Central Time) and will include presentations by members of Hologic's management team, as well as customers using two of Hologic's products.
Advertisement
Interested participants may listen to the call (listen-only mode) by dialing 800-299-7089 or 617-801-9714, passcode 79007028, beginning at 7:50 a.m. (Central Time) and referencing the Hologic Investor Meeting. For those unable to participate in the live broadcast, a replay will be available one hour after the call ends through Tuesday, December 15, 2009, at 888-286-8010 or 617-801-6888, passcode 92355143.
Interested parties are invited to listen to a live audio webcast of Hologic's presentation on the investor section of the company's website at www.hologic.com/investor. An archive of the presentation will be available for replay following the event.
About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.
Contact: Deborah Gordon Vice President, Investor Relations Hologic, Inc. (781) 999-7716
SOURCE Hologic, Inc.
